TL;DR
This case report explores cryoneurolysis, a minimally invasive nerve ablation technique, as a novel treatment for dorsal foot pain and toe clawing in a patient with Multiple Sclerosis (MS). The study demonstrates promising immediate and sustained relief, suggesting cryoneurolysis as a potential therapeutic option for these debilitating symptoms in MS patients.
What Problem Does This Paper Address?
Patients with Multiple Sclerosis (MS) frequently experience altered movement patterns, including toe clawing, which can lead to pain, increased fall risk, and reduced gait efficiency. Toe clawing is often attributed to the flexor digitorum longus (FDL) muscle. Concurrently, neuropathic pain on the dorsum of the foot is another common and challenging symptom in MS. While botulinum toxin (BoNT) injections offer some relief for toe clawing, their efficacy is limited in duration and they do not address foot pain. Existing treatments for these combined issues are often insufficient or invasive. This paper investigates cryoneurolysis, a technique that uses extreme cold to ablate nerves, as a potential solution for both toe clawing and neuropathic foot pain in an MS patient.
Methods
The study employed a case report methodology, adhering to CARE guidelines. The patient, a 50-year-old woman with a 20-year history of MS, presented with chronic dorsal foot pain and dystonic toe clawing.
The treatment involved a two-pronged approach using cryoneurolysis:
- For Toe Clawing: The intramuscular tibial nerve motor branch to the FDL was targeted. This involved ultrasound-guided visualization of the nerve, followed by a diagnostic nerve block (DNB) with lidocaine to confirm the target. Subsequently, a cryoprobe was used to create two lesions along the FDL motor branch.
- For Dorsal Foot Pain: The superficial fibular nerve, responsible for sensory innervation to the dorsum of the foot, was targeted. Similar to the FDL treatment, ultrasound guidance and a DNB were performed, followed by cryoneurolysis to create two lesions above and below the superficial fibular nerve.
Each cryoneurolysis lesion involved a 106-second freezing and thawing cycle. The procedure was performed bilaterally.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- Dual Targeting for Combined Symptoms: The study successfully demonstrated that cryoneurolysis can be used to simultaneously address two distinct but often co-occurring symptoms in MS: motor dysfunction (toe clawing) and sensory dysfunction (neuropathic pain).
- Minimally Invasive and Targeted Approach: Cryoneurolysis offers a less invasive alternative to surgical neurolysis, with ultrasound guidance and electrical stimulation allowing for precise targeting of specific nerve branches, thereby minimizing the risk of unintended motor or sensory deficits.
- Potential for Sustained Relief: The patient experienced significant and lasting relief from both toe clawing and neuropathic pain, with benefits persisting for up to 5.5 months, necessitating retreatment. This suggests a potentially durable effect beyond what is typically seen with other interventions like BoNT.
- Patient-Reported Efficacy: The patient's subjective experience highlights the transformative impact of the treatment, describing it as a "miracle treatment" and a "Christmas gift," underscoring the significant improvement in her quality of life and functional independence.
Key Results
- Immediate Pain Relief: The patient reported complete elimination of neuropathic pain on the dorsum of the foot immediately post-procedure.
- Immediate Reduction in Toe Clawing: Toe clawing was immediately reduced during gait, and the patient regained the ability to voluntarily spread her toes.
- Improved Gait and Confidence: Within 12 weeks, the patient reported improved confidence in her gait, maintained independence, and reduced toe clawing.
- Sustained Benefits: The positive effects lasted for approximately 5.5 months before symptoms returned, prompting retreatment which reproduced the benefits.
- No Adverse Events: The procedure was well-tolerated, with no adverse events reported during or immediately after the treatment. Mild residual pain and bruising at the injection site were transient.
Limitations and Future Work
- Single Case Report: The primary limitation is that this is a case report of a single patient. The findings are not generalizable to the entire MS population, as MS is a diverse and progressive illness with varying responses to treatment.
- Subjective Outcome Measures: The study relies heavily on patient-reported outcomes. The authors suggest that future research should validate objective assessment techniques for dystonic toe clawing.
- Need for Further Research: The authors emphasize the need for well-designed randomized controlled trials to validate the efficacy of cryoneurolysis for toe clawing and neuropathic pain in MS and to compare it with other treatment options. Future studies should also aim to understand the long-term efficacy and optimal retreatment intervals.
Summary updated